心脏重症监护病房住院患者出血管理:波兰心脏学会心脏重症监护协会与心血管药物治疗分会专家意见
该专家意见由波兰心脏学会心脏重症监护协会与心血管药物治疗分会联合其他领域专家制定,针对心脏重症监护病房(ICCU)中急性冠脉综合征、急慢性心力衰竭加重、心源性休克、心脏骤停、电风暴及需紧急心脏外科手术的患者。这些患者多需使用1种、2种甚至3种作用于凝血通路的药物,抗血栓治疗在预防血栓栓塞事件的同时增加出血风险,且出血对预后的不良影响常甚于原发病。文件给出了出血风险降低与出血治疗的实用推荐,并因患者合并症多、出血来源器官多样而纳入其他专科专家的建议。
要点
- ICCU患者常需1种、2种甚至3种作用于凝血通路的药物,抗血栓治疗增加出血风险。
- 在该人群中,出血对预后的不良影响常甚于原发病。
- 专家意见涵盖ICCU住院患者出血风险降低与出血治疗的实用推荐。
- 因合并症多、出血来源器官多样,文件纳入其他领域专科专家的推荐。
适用人群与场景
- ICCU收治的急性冠脉综合征、急性及慢性心力衰竭加重、心源性休克、心脏骤停、电风暴患者,以及有紧急心脏外科手术指征的患者。
研究设计与关键结果
- 该文件为波兰心脏学会心脏重症监护协会与心血管药物治疗分会联合其他领域专家制定的专家意见,给出ICCU住院患者出血风险降低与出血治疗的实用推荐。
证据类型、等级与局限
- 证据类型:专家意见(波兰心脏学会心脏重症监护协会与心血管药物治疗分会联合其他领域专家)。
- 局限:原文未报告局限性
对床旁实践的改变
- 原文未据此给出推荐。
指南或共识出处
- 波兰心脏学会心脏重症监护协会与心血管药物治疗分会专家意见,联合其他领域专家制定。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Nowadays, the intensive cardiac care unit (ICCU) provides care for patients with acute coronary syndrome, acute and exacerbated chronic heart failure, cardiogenic shock, sudden cardiac arrest, electrical storm, as well as with indications for urgent cardiac surgical treatment. Most of these patients require the use of 1, 2, or frequently even 3 drugs that act on the blood coagulation pathway. While antithrombotic drugs prevent thromboembolic events, they are associated with a higher risk of bleeding. In this population of patients, bleeding may often have a worse impact on prognosis than the primary disease. In this expert opinion of the Association of Intensive Cardiac Care, we presented practical guidelines on the management of bleeding in patients hospitalized at the ICCU, including bleeding risk reduction and treatment recommendations. Because of multiple comorbidities and diverse organs that may be the source of bleeding, we provided also recommendations from specialists in other fields of medicine. We hope that this document will facilitate the management of one of the most challenging populations at the ICCU.
参考来源
- Kuliczkowski W, Gierlotka M, Tycińska A, et al. Management of bleeding in patients hospitalized in the intensive cardiac care unit: expert opinion of the Association of Intensive Cardiac Care and Section of Cardiovascular Pharmacotherapy of the Polish Cardiac Society in cooperation with specialists in other fields of medicine. Kardiol Pol. 2019. PMID: 31815926. doi:10.33963/KP.15097
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。